Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.25 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
89 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
73 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 - 2 |
Vancomycin (Vancocyn, Lyphocin) |
72 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
1 - 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
4 |
0.12 - 16 |
Teicoplanin (Targocid) |
67 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
4 |
≤0.12 - 16 |
Teicoplanin (Targocid) |
162 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
8 |
0.125 - 16 |
Teicoplanin (Targocid) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
8 |
0.25 - 16 |
Teicoplanin (Targocid) |
72 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
16 |
0.03 - 64 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.25 - 4 |
Oritavancin (LY333328) |
207 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 - 2 |
Oritavancin (LY333328) |
72 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 - 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 - 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
4 |
0.5 - 4 |
Meticillin (Methicillin, Staphcillin) |
178 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
8 |
≤0.06 - 16 |
Ceftriaxone (Rocephin) |
371 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
8 |
≤0.12 - 16 |
Teicoplanin (Targocid) |
73 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
16 |
0.25 - >32 |
Ceftriaxone (Rocephin) |
102 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
16 |
0.5 - 128 |
Ampicillin (Omnipen) |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
4 |
64 |
≤0.12 - 128 |
Piperacillin (Pipracil) |
89 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
8 |
32 |
8 - 64 |
Mannopeptimycins (γ) |
89 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
16 |
32 |
8 - >128 |
D-ofloxacin |
117 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
64 |
64 |
4 - 128 |
Thymol |
1464 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
0.12 |
? - ? |
Ceftaroline |
1358 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
1.5 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1112 |
Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
2 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
1358 |